Vivax Elimination With Tafenoquine (VET) Study

Clinical trial NCT06575647 · COMPLETED

Trial details

NCT number: NCT06575647
Sponsor: Shoklo Malaria Research Unit
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Malaria Malaria, Vivax Plasmodium Vivax Plasmodium Vivax Malaria

Start date: 2025-02-19
Primary completion: 2025-10-04
Enrollment: 1242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.